Publications
-
Increased risk of arthropathies and joint replacement surgery in patients with genetic hemochromatosis: a study of 3,531 patients and their 11,794 first-degree relatives.
Elmberg M,
Hultcrantz R, Simard JF, Carlsson A, Askling J.
Arthritis Care Res (Hoboken).
2013;
65
(5):
678-85
-
Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes.
Simard JF,
Baecklund F, Chang ET, Baecklund E, Hjalgrim H, -Olov Adami H, Glimelius B, Smedby KE.
Int J Cancer.
2013;
132
(11):
2659-66
-
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.
Olofsson T,
Petersson IF, Eriksson JK, Englund M, Simard JF, Nilsson JA, Geborek P, Jacobsson LT, Askling J, Neovius M.
Ann Rheum Dis.
2013
-
Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
Leval A,
Herweijer E, Ploner A, Eloranta S, Fridman Simard J, Dillner J, Young C, Netterlid E, Sparén P, Arnheim-Dahlström L.
J Natl Cancer Inst.
2013;
105
(7):
469-74
-
Reply.
Simard JF,
Neovius M, Askling J.
Arthritis Rheum.
2013
-
Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden.
Raaschou P,
Simard JF, Holmqvist M, Askling J.
BMJ.
2013:
346
f1939
-
Incidence of Rheumatoid Arthritis in Sweden - a nationwide population-based assessment of incidence, its determinants, and treatment penetration.
Eriksson JK,
Neovius M, Ernestam S, Lindblad S, Simard JF, Askling J.
Arthritis Care Res (Hoboken).
2012
-
Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability.
Leval A,
Herweijer E, Arnheim-Dahlström L, Walum H, Frans E, Sparén P, Simard JF.
J Infect Dis.
2012;
206
(6):
860-6
-
Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease.
Ludvigsson JF,
Rubio-Tapia A, Chowdhary V, Murray JA, Simard JF.
J Rheumatol.
2012;
39
(10):
1964-70
-
Is there a sex bias in prescribing anti-tumour necrosis factor medications to patients with rheumatoid arthritis? A nation-wide cross-sectional study.
Arkema EV,
Neovius M, Joelsson JK, Simard JF, van Vollenhoven RF.
Ann Rheum Dis.
2012;
71
(7):
1203-6
-
Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register.
Simard JF,
Neovius M, Askling J.
Arthritis Rheum.
2012;
64
(11):
3502-10
-
Rheumatoid factor positivity in the general population.
Simard JF,
Holmqvist M.
BMJ.
2012:
345
e5841
-
Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.
Gustafsson JT,
Simard JF, Gunnarsson I, Elvin K, Lundberg IE, Hansson LO, Larsson A, Svenungsson E.
Arthritis Res Ther.
2012;
14
(2):
R46
-
Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study.
Elmberg M,
Hultcrantz R, Simard JF, Stål P, Pehrsson K, Askling J.
J Intern Med.
2012;
272
(1):
45-54
-
Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis.
Ljung L,
Simard JF, Jacobsson L, Rantapää-Dahlqvist S, Askling J.
Arthritis Rheum.
2012;
64
(1):
42-52
-
Does cancer that occurs during or after anti-tumor necrosis factor therapy have a worse prognosis? A national assessment of overall and site-specific cancer survival in rheumatoid arthritis patients treated with biologic agents.
Raaschou P,
Simard JF, Neovius M, Askling J.
Arthritis Rheum.
2011;
63
(7):
1812-22
-
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register.
Neovius M,
Simard J, Sundström A, Jacobsson L, Geborek P, Saxne T, Feltelius N, Klareskog L, Askling J.
Ann Rheum Dis.
2011;
70
(3):
516-9
-
How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?
Neovius M,
Simard JF, Askling J.
Ann Rheum Dis.
2011;
70
(6):
1010-5
-
Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden.
Neovius M,
Simard JF, Askling J.
Ann Rheum Dis.
2011;
70
(4):
624-9
-
Pediatric organ transplantation and risk of premalignant and malignant tumors in Sweden.
Simard JF,
Baecklund E, Kinch A, Brattström C, Ingvar A, Molin D, Adami J, Fernberg P, Wilczek H, Ekbom A, Smedby KE.
Am J Transplant.
2011;
11
(1):
146-51
-
Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice.
Neovius M,
Simard JF, Klareskog L, Askling J.
Ann Rheum Dis.
2011;
70
(8):
1407-14
-
Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009.
Neovius M,
Sundström A, Simard J, Wettermark B, Cars T, Feltelius N, Askling J, Klareskog L.
Scand J Rheumatol.
2011;
40
(1):
8-15
-
Ten years with biologics: to whom do data on effectiveness and safety apply?
Simard JF,
Arkema EV, Sundström A, Geborek P, Saxne T, Baecklund E, Coster L, Dackhammar C, Jacobsson L, Feltelius N, Lindblad S, Rantapää-Dahlqvist S, Klareskog L, van Vollenhoven RF, Neovius M, Askling J.
Rheumatology (Oxford).
2011;
50
(1):
204-13
-
Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients.
Fernberg P,
Edgren G, Adami J, Ingvar A, Bellocco R, Tufveson G, Höglund P, Kinch A, Simard JF, Baecklund E, Lindelöf B, Pawitan Y, Smedby KE.
Am J Transplant.
2011;
11
(11):
2472-82
-
A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus.
Svenungsson E,
Gustafsson J, Leonard D, Sandling J, Gunnarsson I, Nordmark G, Jönsen A, Bengtsson AA, Sturfelt G, Rantapää-Dahlqvist S, Elvin K, Sundin U, Garnier S, Simard JF, Sigurdsson S, Padyukov L, Syvänen AC, Rönnblom L.
Ann Rheum Dis.
2010;
69
(5):
834-40
-
Early life factors and adult-onset rheumatoid arthritis.
Simard JF,
Costenbader KH, Hernán MA, Liang MH, Mittleman MA, Karlson EW.
J Rheumatol.
2010;
37
(1):
32-7
-
Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study.
Simard JF,
Neovius M, Hagelberg S, Askling J.
Arthritis Rheum.
2010;
62
(12):
3776-82
-
Validity of self-report of infections in a longitudinal cohort of patients with rheumatoid arthritis differs by source of report and infection severity.
Simard JF,
Stoll ML, Shadick NA, Karlson EW, Solomon DH.
J Clin Epidemiol.
2010;
63
(12):
1358-62
-
Exposure to maternal smoking and incident SLE in a prospective cohort study.
Simard JF,
Costenbader KH, Liang MH, Karlson EW, Mittleman MA.
Lupus.
2009;
18
(5):
431-5
-
Is birthweight associated with risk of rheumatoid arthritis? Data from a large cohort study.
Mandl LA,
Costenbader KH, Simard JF, Karlson EW.
Ann Rheum Dis.
2009;
68
(4):
514-8
-
Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus.
Liang MH,
Simard JF, Costenbader K, Dore BT, Ward M, Fortin PR, Illei GG, Manzi S, Mittleman B, Buyon J, Gupta S, Abrahamowicz M.
Endocr Metab Immune Disord Drug Targets.
2009;
9
(1):
108-12
-
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.
Gustafsson J,
Gunnarsson I, Börjesson O, Pettersson S, Möller S, Fei GZ, Elvin K, Simard JF, Hansson LO, Lundberg IE, Larsson A, Svenungsson E.
Arthritis Res Ther.
2009;
11
(6):
R186
-
TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma.
Stoll ML,
Solomon DH, Batra KL, Simard JF, Karlson EW, Dellaripa PF, Weinblatt ME, Glass R, Shadick NA.
J Clin Rheumatol.
2009;
15
(4):
198-200
-
Exposure to cigarette smoke in utero: comparison of reports from mother and daughter.
Simard JF,
Rosner BA, Michels KB.
Epidemiology.
2008;
19
(4):
628-33
-
Perinatal factors and adult-onset lupus.
Simard JF,
Karlson EW, Costenbader KH, Hernán MA, Stampfer MJ, Liang MH, Mittleman MA.
Arthritis Rheum.
2008;
59
(8):
1155-61
-
Prevalent rheumatoid arthritis and diabetes among NHANES III participants aged 60 and older.
Simard JF,
Mittleman MA.
J Rheumatol.
2007;
34
(3):
469-73
-
What can epidemiology tell us about systemic lupus erythematosus?
Simard JF,
Costenbader KH.
Int J Clin Pract.
2007;
61
(7):
1170-80
-
Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.
Finckh A,
Simard JF, Gabay C, Guerne PA.
Ann Rheum Dis.
2006;
65
(6):
746-52
-
The effectiveness of anti-tumor necrosis factor therapy in preventing progressive radiographic joint damage in rheumatoid arthritis: a population-based study.
Finckh A,
Simard JF, Duryea J, Liang MH, Huang J, Daneel S, Forster A, Gabay C, Guerne PA.
Arthritis Rheum.
2006;
54
(1):
54-9
-
The large print giveth and the small print taketh away: preemptive treatment of serologically active, clinically quiet systemic lupus erythematosus.
Liang MH,
Simard JF.
Arthritis Rheum.
2006;
54
(11):
3378-80
Help